Changes of pulse wave velocity findings and the effects of folic acid treatment on homocysteine levels in End Stage Renal Disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Korean Journal of Internal Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of serum albumin and homocysteine levels and cardio-ankle vascular index in patients with continuous ambulatory peritoneal dialysis

  2006cited by this paper
• [Homocysteine lowering with folic acid and B vitamins in vascular disease].

  2006cited by this paper
• Homocysteine lowering and cardiovascular events after acute myocardial infarction.

  2006cited by this paper
• Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study

  2006cited by this paper
• Comparison of changes in pulse wave velocity in patients on continuous ambulatory peritoneal dialysis and hemodialysis one year after introduction of dialysis therapy.

  2005cited by this paper
• Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials.

  2005cited by this paper
• Folic acid supplementation to prevent adverse events in individuals with chronic kidney disease and end stage renal disease

  2005cited by this paper
• Risk factors for coronary artery disease in patients with renal failure.

  2003cited by this paper
• Randomized, placebo‐controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients

  2003cited by this paper
• Traditional and emerging cardiovascular risk factors in end-stage renal disease.

  2003cited by this paper
• Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia

  2003cited by this paper
• Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia.

  2003cited by this paper
• Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction.

  2003cited by this paper
• Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.

  2002cited by this paper
• Homocysteine and cardiovascular disease: current evidence and future prospects.

  2002cited by this paper
• The C677T thermolabile variant of methylene tetrahydrofolate reductase on homocysteine, folate and vitamin B12 in a hemodialysis center.

  2002cited by this paper
• C-Reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD

  2000cited by this paper
• PLASMA HOMOCYSTEINE LEVELS AND MORTALITY IN PATIENTS WITH CORONARY ARTERY DISEASE

  2000cited by this paper
• Homocysteine and atherosclerosis.

  1999cited by this paper
• The epidemic of cardiovascular disease in end-stage renal disease.

  1999cited by this paper
• Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease.

  1998cited by this paper
• Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.

  1997cited by this paper
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

  1995cited by this paper
• Vitamin requirements for the treatment of hyperhomocysteinemia in humans.

  1994cited by this paper
• Plasma homocysteine in renal failure.

  1993cited by this paper
• Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients.

  1993cited by this paper
• The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine.

  1992cited by this paper
• Hyperhomocysteinemia: an independent risk factor for vascular disease.

  1991cited by this paper
• Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.

  1990cited by this paper
• Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease.

  1988cited by this paper
• Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.

  1988cited by this paper
• Folie acid dosage for chronic hemodialysis patients

  1975cited by this paper

• No citing papers are available for this paper.